HOOK
Hookipa Pharma Inc
Halal Rating :
Last Price
$1.93
Last updated:
Market Cap
-
7D Change
8.43%
1 Year Change
190.18%
Company Overview
Industries
Exchange
Next Earnings Date
Hookipa Pharma Inc is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company is focused on developing preventative and therapeutic vaccines that harness the immune system to fight infectious diseases and cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.7m | $23.35m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.29m | $23.75m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $36.6m | $25.5m | - | $2000.0 | 0.00% | 0.01% |
Company Impact
Help us evaluate Hookipa Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.